PAVM news

Latest 1 stories · newest Nov 12, 2026

PAVM

Lucid Diagnostics reports Medicare coverage for EsoGuard test

Lucid Diagnostics announced full Medicare reimbursement for the EsoGuard esophageal DNA test, a major milestone for the company. The announcement marks the beginning of a new commercialization phase and includes record test volumes.

Regulatory Nov 12, 2026 sentiment +0.70 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same PAVM feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/PAVM/newsSTART FREE